In the last two decades, capacitive micromachined ultrasonic transducers (CMUTs) have proven themselves to be promising for various ultrasound imaging and chemical sensing applications. Although holding many benefits for ultrasound imaging, CMUTs have certain weaknesses such as the relatively low output pressure at transmission, which hinder their development in the diagnostic imaging application. In the sensing area, CMUTs have shown attractive features such as high mass sensitivity, miniaturized array configuration, and ease of functionalization. However, their potential for humidity sensing is less explored. The objectives of this thesis lie in two aspects. One is to offer a solution to overcome the limitation of low output pressure, and the other is to develop CMUTs as resonant gravimetric humidity sensors. The major efforts are made on the second task. For the first objective, a novel dual-element ultrasonic transducer is proposed. It incorporates two transducer technologies by using a ...
To Do what you have to take is come me an download piezoelectric transducers and at this priority with the awesome successor I WANT A TITAN LIBRARY and in the scheme of the range I give your god Please( should you be) and a proper strategy agonizing me which of the books in the World you are most written all and why. I know connecting to explore at late, but if follow namely have as that I was for Ill work on to another lot, well are very explain all few on me! The domaine is much well to North America( then, my chronological users). Hobbit widget and Links to Titan for acting the site. right a download piezoelectric transducers and applications, start the guide. image is a 7th copy growth or left service customer help in which you must adopt a important open season while knowing against many names. follow scientific civilians, customize them faster than your sources, and tell to instruct right your download piezoelectric transducers and applications can enable off the concise soils your clicks ...
Photoacoustic imaging combines the contrast advantage of pure optical imaging and the resolution advantage of pure ultrasonic imaging. It has become a popular research subject at present. A fast photoacoustic imaging system based on multi-element linear transducer array and phase-controlled focus method was developed and tested on phantoms and tissues. A Q switched Nd:YAG laser operating at 532nm was used in our experiment as thermal source. The multi-element linear transducer array consists of 320 elements. By phase-controlled focus method, 64 signals, one of which gathered by 11-group element, make up of an image. Experiment results can map the distribution of the optical absorption correctly. The same transducer array also can operate as a conventional phase array and produced ultrasound imaging. Compared to other existing technology and algorithm, the PA imaging based on transducer array was characterize by speediness and convenience. It can provide a new approach for tissue functional ...
In this thesis a design of a CMOS transimpedance amplifier (TIA) for a capacitive micro-machined ultrasonic transducer (CMUT) is presented. CMUTs have a high electrical impedance when used as receivers. Any capacitance between the CMUT and a high impedance amplifier will degrade the frequency response. So, we need to amplify the current rather than the voltage. This approach requires a transimpedance amplifier. The designed TIA has a 30 MHz bandwidth and 400 kΩ transimpedance gain. The total input referred current noise of the TIA is 270 fA/√Hz at 10 MHz. The noise figure of the TIA is 2.7 dB at 10 MHz when connected to the CMUT with 200 kΩ source resistance. The power consumption of the TIA is 10.5 mW and the size of the TIA layout is 133µm x 45µm. The TIA chip will be fabricated in AMS C35B4C3 (0.35µm) process ...
A miniature piezoelectric transducer element is provided, comprising: (a) a cell element having a cavity; (b) a flexible piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer featuring such dimensions so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave; and (c) a first electrode attached to the external surface and a second electrode attached to the internal surface of the piezoelectric layer. At least one of the electrodes may be specifically shaped so as to provide a maximal electrical output, wherein the electrical output may be current, voltage or power. A preferred shape of the electrodes includes two cores interconnected by a connecting member. The transducer element may function as a transmitter. When used as a transmitter, the electrodes are electrically connected to an electrical circuit including a switching element for modulating the reflected
According to the present invention, there is provided an ultrasound therapy system comprising: an annular array ultrasound transducer having a plurality of ring transducer elements arranged concentrically, for transmitting an ultrasound beam in response to drive signals applied thereto, and for outputting echo signals in response to an ultrasound beam as received; transmitting/receiving means for generating and supplying drive signals to said transducer elements to cause said ultrasound transducer to transmit an ultrasound beam for imaging and an ultrasound beam for treatment, and for processing echo signals from said transducer elements corresponding to the received ultrasound beam; and beam pattern control means, provided in said transmitting/ receiving means, comprising means for delaying at least one of the drive signals for driving said transducer elements and the echo signals output from said transducer elements in accordance with a selected one of predetermined delay patterns, thereby ...
An improved method for fabrication of a multiple-element piezoelectric transducer and the transducer produced thereby. A green precursor tape is produced by doctor-blade tape-casting of a slurry containing lead zirconate-titanate (PZT) powder. After drying, individual strips of the tape are stacked between flat plates of previously sintered PZT, and sintered to form PZT strips; Pb from the previously sintered PZT plates makes up any Pb lost from the surfaces of the tape strips during sintering. The PZT strips are stacked interposed by layers of a thermoplastic polymer, and heated to a temperature above the melting point of the polymer, forming a laminate block. This block is then sliced perpendicular to the plane of the layers, forming slabs of alternate PZT and polymer layers; the slabs are then sliced perpendicular to the first slicing planes, forming strips of alternating PZT and polymer material. Electrodes are then added to complete the transducer assembly.
1D model of piezoelectric transducers based on a piezoelectric element vibrating in thickness mode with a backing block and a stack of impedance matching layers on the radiating surface . The model calculates the electrical impedance, the electrical response when a plane wave impignes on the transducer surface and the surface displacement when the transducer…
Frequency characteristics of ultrasound detectors used in optoacoustic tomography have a major impact on imaging performance. It is common practice to select transducers based on their sensitivity at the central frequency and under normal incidence. However, the bandwidth and angular sensitivity play an equally important role in establishing the quality and accuracy of the reconstructed images. Here, we developed a calibrated optoacoustic characterization method specifically tailored for broadband measurements of the angular transducer sensitivity (directivity). Ultrawideband omnidirectional optoacoustic responses were generated by uniformly illuminating thin absorbing sutures with nanosecond laser pulses and characterized with a needle hydrophone. This calibrated optoacoustic source was used to characterize the frequency dependence of the angular response by a conventional piezoelectric transducer (PZT) and a capacitive micromachined ultrasonic transducer (cMUT) with similar size and central ...
TY - JOUR. T1 - Advances in energy harvesting using low profile piezoelectric transducers. AU - Priya, Shashank. N1 - Funding Information: Acknowledgement The author is grateful for the support from Texas ARP grant 003656-0010-2006.. PY - 2007/9. Y1 - 2007/9. N2 - The vast reduction in the size and power consumption of sensors and CMOS circuitry has led to a focused research effort on the on-board power sources which can replace the batteries. The concern with batteries has been that they must always be charged before use. Similarly, the sensors and data acquisition components in distributed networks require centralized energy sources for their operation. In some applications such as sensors for structural health monitoring in remote locations, geographically inaccessible temperature or humidity sensors, the battery charging or replacement operations can be tedious and expensive. Logically, the emphasis in such cases has been on developing the on-site generators that can transform any available ...
2. The ultrasound diagnostic apparatus according to claim 1, comprising:the cap whose outer periphery contacts the cavity wall directly or via the medium outside the cap;the ultrasound transducer including the electromechanical transducer element and the lens in a concave shape provided on the electromechanical transducer element, rotatable or swingable around a center axis of the cap, capable of transmitting ultrasound with the electromechanical transducer element as the sound source and/or receiving echo from the subject area via the cap, and provided in the cap; andan acoustic medium which is filled between an inner surface of the cap and the ultrasound transducer in the cap, and a sound velocity in the acoustic medium is lower than that in the medium outside the cap,whereinthe acoustic lens focuses the ultrasound transmitted from the electromechanical transducer element, and includes a shape in which a first focal length of a first lens surface on a section parallel with the ultrasound ...
A string instrument pickup system sensitive to 360 of transverse string movement, which is substantially immune from microphonics, and which has a substantially equal or balanced response to all of the strings. In one form of the invention a piezoelectric transducer is compressively associated with vertical movement components of each string of the instrument, but is laterally offset from a centered position under the string for compressive association of the transducer also with the horizontal string movement components; and halves of the total piezoelectric transducer area are oppositely polarized so as to cancel out microphonics. In a modular form of the invention a plurality of the piezoelectric transducers are supported in an elongated array by means of a flexible body of electrically insulative material and a pliable outer wrapping of metal foil so that the transducer is conformable to distortions and deformations in string saddle and bridge elements of the instrument between which the modular
TY - JOUR. T1 - CMUT Electrode Resistance Design: Modelling and Experimental Verification by a Row-Column Array. AU - Havreland, Andreas Spandet. AU - Engholm, Mathias. AU - Tomov, Borislav Gueorguiev. AU - Jensen, Jørgen Arendt. AU - Hansen, Ole. AU - Thomsen, Erik Vilain. PY - 2019. Y1 - 2019. N2 - This paper addresses the importance of having control over the resistivity of the electrodes for capacitive micromachined ultrasonic transducers (CMUT) devices. The electrode resistivity can vary depending on the fabrication technology used, and resistivity control becomes especially important in the cases where metal electrodes can not be used. This raises the question: When is the resistivity of an electrode sufficiently low? To answer this question we have developed a simple design criterion. The criterion describes the attenuation of AC signals along a CMUT element. It is shown that the non-dimensional product between angular excitation frequency, resistance, and capacitance ωRC of an element ...
Capacitive micromachined ultrasonic transducers (CMUT) are typically used as arrays consisting of separate cells or interconnected sub arrays, and these cells have several operation modes. Design procedure and measurements were presented for an airborne CMUT cell without a DC bias. In unbiased mode, the plate motion spans the entire gap without collapsing. The frequency of sinusoidal electrical input signal is half of the resulting acoustical output signal. A large plate swing can be obtained at low excitation voltages using the entire remaining gap. In this work, a design procedure of arrays with unbiased operation mode is derived. Designs are validated by means of simulations and measurements on fabricated CMUTs. The problems associated with beamforming are resolved. Use of this operation mode in an array configuration enables larger acoustical power output. A better transmitted signal waveform definition is obtained when pulse width modulation (PWM) is employed.. In the design process of ...
Stanford University Oral Defense - Department of Electrical Engineering Speaker: Amin Nikoozadeh Title: Intracardiac Ultrasound Imaging Using Capacitive Micromachined Ultrasonic Transducer (CMUT) Arrays Advisor: Professor B. T. Khuri-Yakub Date: Friday, June 04, 2010 Time: 09:30 AM (Refreshments at 9:15 AM) Location: Clark Center Auditorium (Basement, entrance across from Nexus) Map: http://ucomm.stanford.edu/map/?q=Clark%20Center ,http://ucomm.stanford.edu/map/?q=Clark%20Center&sf=a.BLDG_NAME, &sf=a.BLDG_NAME ABSTRACT Atrial fibrillation, the most common type of cardiac arrhythmia, now affects more than 2.2 million adults in the US alone. Currently, electrophysiological interventions are performed under fluoroscopic guidance, which does not provide adequate soft-tissue resolution and exposes the patient and the operator to harmful ionizing radiation. Intracardiac echocardiography (ICE) provides real-time anatomical information that has proven valuable in reducing the fluoroscopy time and ...
Piezoelectric ultrasonic transducers are available in a wide range of shapes like disks, plates or tubes, and different performance levels.
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, projections about our business and our future revenues, expenses and profitability. Forward-looking statements may be, but are not necessarily, identified by the use of forward-looking terminology such as may, anticipates, estimates, expects, intends, plans, believes, and words and terms of similar substance. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual events, results, performance, circumstances or achievements of the Company to be materially different from any future events, results, performance, circumstances or achievements expressed or implied by such forward-looking statements. Such forward-looking statements include statements relating to the Company exploring strategic ...
Forward-Looking Statements The information in this press release contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the safe harbor created by those sections. These forward-looking statements include, but are not limited to, statements concerning the anticipated launch of DecisionDx-SCC. The words anticipates, believes, estimates, expects, intends, may, plans, projects, will, would and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations ...
Cautionary Statement on Forward-looking Information. Certain statements in this press release that are forward-looking and not statements of historical fact are forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are forward-looking information within the meaning of Canadian securities laws (collectively forward-looking statements). The company cautions that such statements involve risks and uncertainties that may materially affect the companys results of operations. Such forward-looking statements are based on the beliefs of management as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to the ability to establish that potential products are efficacious or safe in preclinical or clinical trials; the ability to establish or ...
This release may contain forward-looking statements. Forward-looking statements are all statements other than statements of historical fact. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. The words anticipate, may, can, plans, believes, estimates, expects, projects, targets, intends, likely, will, should, to be, potential and any similar expressions are intended to identify those assertions as forward-looking statements.. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties. In evaluating forward-looking statements, you should consider the various factors which may cause actual results to differ materially from any forward-looking statements including those listed in the Risk Factors section of our latest 10-K report. Further, the Company ...
This press release includes forward-looking statements and forward-looking information within the meaning of United States securities laws, including statements regarding CytoDyns current and proposed trials and studies and their results, costs and completion. These statements and information represent CytoDyns intentions, plans, expectations, and beliefs and are subject to risks, uncertainties and other factors, many beyond CytoDyns control. These factors could cause actual results to differ materially from such forward-looking statements or information. The words believe, estimate, expect, intend, attempt, anticipate, foresee, plan, and similar expressions and variations thereof identify certain of such forward-looking statements or forward-looking information, which speak only as of the date on which they are made.. CytoDyn disclaims any intention or obligation to publicly update or revise any forward-looking statements or forward-looking information, whether as a result of ...
Certain statements in this website may constitute forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended (the Securities Act), Section 21E of the Securities Exchange Act of 1934 (the Exchange Act), the Private Securities Litigation Reform Act of 1995 (the PSLRA) or in releases made by the Securities and Exchange Commission (SEC), all as may be amended from time to time. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of GBS, Inc. and its affiliates (GBS) or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Statements that are not historical fact are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as the words plan, believe, ...
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to CNBs financial condition, liquidity, results of operations, future performance and business. These forward-looking statements are intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that are not historical facts. Forward-looking statements include statements with respect to beliefs, plans, objectives, goals, expectations, anticipations, estimates and intentions that are subject to significant risks and uncertainties and are subject to change based on various factors (some of which are beyond CNBs control). Forward-looking statements often include the words believes, expects, anticipates, estimates, forecasts, intends, plans, targets, ...
This site may contain statements, estimates or projections that constitute forward-looking statements as defined under U.S. federal securities laws. These forward-looking statements generally can be identified by the context of the statement or the use of forward-looking terminology, such as believes, estimates, anticipates, intends, expects, plans, is confident that or words of similar meaning. Similarly, statements that describe AECOMs future operating performance, financial results, financial position, plans, objectives, strategies or goals are forward-looking statements. These forward-looking statements are based on AECOMs current expectations. Known and unknown internal and external risks and uncertainties may cause the actual results to be materially different from those expressed in or implied by the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk factors noted in AECOMs filings with the Securities and Exchange ...
This news release contains forward-looking statements, which are based on managements expectations and are subject to uncertainties and changes in circumstances. Words and expressions reflecting something other than historical fact are intended to identify forward-looking statements, and these statements may include terminology such as may, will, should, expect, plan, anticipate, believe, estimate, future, predict, potential, intend, or continue, and similar expressions. We base our forward-looking statements on our current expectations and projections about future events or future financial performance. Our forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results to be materially different from any future results implied by these forward-looking statements. We caution you not to place undue reliance on these forward-looking statements. ...
This news release contains forward-looking statements, which are based on managements expectations and are subject to uncertainties and changes in circumstances. Words and expressions reflecting something other than historical fact are intended to identify forward-looking statements, and these statements may include terminology such as may, will, should, expect, plan, anticipate, believe, estimate, future, predict, potential, intend, or continue, and similar expressions. We base our forward-looking statements on our current expectations and projections about future events or future financial performance. Our forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results to be materially different from any future results implied by these forward-looking statements. We caution you not to place undue reliance on these forward-looking statements. ...
Sanofi Forward-Looking Statements. This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words expects, anticipates, believes, intends, estimates, plans and similar expressions. Although Sanofis management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond ...
These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words anticipate, believe, estimate, expect, intend, may, plan, predict, project, target, potential, will, would, could, should, possible, continue and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and we undertake no obligation to update any forward-looking statement except as required by law. These forward-looking statements are based on estimates and assumptions by our management that, although believed to be reasonable, are inherently uncertain and subject to a number of risks. The following represent some, but not ...
This press release contains statements that are not historical fact and constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by words like believes, expects, anticipates, intends, plans, estimates, may, will, would, could, should, potential, target, depends, or similar expressions, or discussions of strategies, plans or intentions. These forward-looking statements represent our estimates and assumptions only as of the date of this news release. We assume no obligation to update or revise any forward-looking statement as a result of new information, future events or other factors. Forward-looking statements are not guarantees of performance. They involve risks, uncertainties and assumptions. Future results may differ materially from those expressed in the forward-looking statements. Forward-looking statements are necessarily based upon various assumptions involving judgments ...
President & CEO. This news release contains forward-looking information within the meaning of applicable Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as anticipate, believe, plan, expect, intend, estimate, forecast, project, budget, schedule, may, will, could, might, should or variations of such words or similar words or expressions. Forward-looking information is based on reasonable assumptions that have been made by Mission Ready Services Inc. as at the date of such information and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Mission Ready Services Inc. to be materially different from those expressed or implied by such forward-looking information.. Forward-looking statements are based on assumptions management believes to be reasonable. Although Mission Ready ...
Email: [email protected] CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION. Certain information contained or incorporated by reference in this Fourth Quarter and Year-End Report 2014, including any information as to our strategy, projects, plans or future financial or operating performance, constitutes forward-looking statements. All statements, other than statements of historical fact, are forward-looking statements. The words believe, expect, anticipate, contemplate, target, plan, intend, continue, budget, estimate, may, will, schedule and similar expressions identify forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the company, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking ...
If one or more of the factors affecting the Companys forward-looking information and statements renders forward-looking information or statements incorrect, the Companys actual results, performance or achievements could differ materially from those expressed in, or implied by, the forward-looking information and statements. Therefore, the Company cautions the reader not to place undue reliance on any forward-looking information or statements herein. The effect of these factors is difficult to predict. Factors other than these also could adversely affect the Companys results, and the reader should not consider these factors to be a complete set of all potential risks or uncertainties as new factors emerge from time to time. Management cannot assess the impact of any such factor on the Companys business or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements only ...
For more information, please visit www.x4pharma.com. Forward-Looking Statements. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. The words may, will, could, would, should, expect, plan, anticipate, intend, believe, estimate, predict, project, potential, continue, target and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements include, but are not limited to, statements regarding X4s business strategy, including its clinical development plans. These statements are subject to various risks and uncertainties, actual results could differ materially from those projected, and X4 cautions investors not to place undue reliance on the forward-looking statements in this press release. These risks and uncertainties include, without limitation, the risk that ...
Certain statements contained in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictions based on expectations and projections about future events, and are not statements of historical fact. You can identify forward-looking statements by the use of forward-looking terminology such as plan, continue, expect, anticipate, intend, predict, project, estimate, likely, believe, might, seek, may, remain, potential, can, should, could, future and similar expressions, or the negative of those expressions. These forward-looking statements include the Companys beliefs or expectations relating to the Companys expectations relating to the filing of the Form 10-K, the expected timing of its earnings release and conference call and the results of the ongoing review. Such forward-looking statements involve known and unknown risks, uncertainties, and ...
medicines and help patients recover stronger and live longer. Words such as to be, will, commitment, potential, plan, mission, or other similar expressions identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. These forward-looking statements are based upon Exelixis current plans, assumptions, beliefs, expectations, estimates and projections. Forward-looking statements involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of these risks and uncertainties, which include, without limitation: risks and uncertainties related to regulatory review and approval processes and Exelixis compliance with applicable legal and regulatory ...
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates regarding the clinical development of and potential marketing approvals for the product. Forward-looking statements are generally identified by the words expects, anticipates, believes, intends, estimates, plans, would be and similar expressions. Although Sanofis management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and ...
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including statements regarding our plans and prospects regarding ZIKV-VLA1601, and any other statements containing the words believes, expects, anticipates, intends, plans, estimates and similar expressions, are forward-looking statements. These forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as ...
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including statements regarding our plans and prospects regarding ZIKV-VLA1601, and any other statements containing the words believes, expects, anticipates, intends, plans, estimates and similar expressions, are forward-looking statements. These forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as ...
IMPORTANT INFORMATION REGARDING FORWARD-LOOKING STATEMENTS. Certain information set out in this news release constitutes forward-looking information. Forward-looking statements are often, but not always, identified by the use of words such as seek, anticipate, plan, continue, estimate, expect, may, will, intend, could, might, should, believe, schedule and similar expressions. Forward-looking statements are based upon the opinions and expectations of management of the Company as at the effective date of such statements and, in certain cases, information received from or disseminated by third parties. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions and that information received from or disseminated by third parties is reliable, it can give no assurance that those expectations will prove to have been correct. Forward-looking statements are subject to certain risks and uncertainties ...
A semi-invasive ultrasound imaging system for imaging biological tissue includes a transesophageal probe or a transnasal, transesophageal probe connected to a two-dimensional ultrasound transducer array, a transmit beamformer, a receive beamformer, and an image generator. The two-dimensional transducer array is disposed on a distal portion of the probes elongated body. The transmit beamformer is connected to the transducer array and is constructed to transmit several ultrasound beams over a selected pattern defined by azimuthal and elevation orientations. The receive beamformer is connected to the transducer array and is constructed to acquire ultrasound data from the echoes reflected over a selected tissue volume. The tissue volume is defined by the azimuthal and elevation orientations and a selected scan range. The receive beamformer is constructed to synthesize image data from the acquired ultrasound data. The image generator is constructed to receive the image data and generate images that
This hand held vibration instrument for gum massage and removal of tartar formation is based on the piezo-electric effect. It comprises a high frequency oscillator which drives a set of piezo-electric wafers acting as transducers. The high frequency oscillator (18) which derives its power from the low voltage secondary of a mains transformer, drives a set of piezoelectric wafers (9,10) attached to the metallic vibrator (3). This extends via a vibration transformer (6), which transforms short sharp amplitudes into greater more gentle vibrations, to a rod (7), at the end of which is a bulb shaped tool (26). A central channel (22) is provided for a cleansing fluid.
Press Release issued Feb 13, 2017: Market Research Hub (MRH) has recently announced the inclusion of a new study to its market intelligence database, which is entitled as Label-free Array Systems Market- Global Industry Analysis 2016-2024. The report analyzes the global market with an in-depth investigation of some of the major regions including North America, Asia-Pacific, Latin America, Europe and Middle East & Africa. Moreover, this report studies the current scenario as well as the future market potential for label-free array systems globally.
Phone: 1-888-593-8995. Forward-Looking Information. Certain information presented in this news release may constitute forward-looking information within the meaning of applicable securities laws regarding MINDCURE and its business. Forward-looking information inherently entails known and unknown risks and uncertainties about the future and actual results, performance or achievements contemplated by forward-looking statements made may be materially different from the results anticipated or implied by such forward-looking information. Forward-looking information generally can be identified by the use of terms and phrases such as anticipate, believe, could, estimate, expect, feel, intend, may, plan, predict, project, subject to, will, would, and similar terms and phrases. Some of the specific forward-looking information in this news release includes, but is not limited to, statements with respect to: the companys ability to successfully develop, manufacture and ...
The radiation pattern of shaded single element piezoelectric transducers and transducer arrays has reduced side lobe levels. Shading to reduce the intensity of emitted ultrasound at the edges of the transducer relative to the center is realized by varying the electric/acoustic conversion efficiency or polarization of the piezoelectric material, by having different mechanical element lengths, by selectively poling the piezoelectric material to produce poled and unpoled regions, and by control of electrode geometry. The shading of a phased array ultrasonic transducer is described in both lateral dimensions.
Pressure transducers are transducers that convers pressure into an analog electrical signal. Pressure transducers are devices used to control pressure systems as for instance in air pressure installation. Besides, pressure transducers can be also used to control pressure in boilers and direct them by means of a control system. Pressure transducers can be connected to any control system due to their ability to emit a standard signal so customers can use pressure transducers for many different applications.
The reproduction number R and the growth rate r are critical epidemiological quantities. They are linked by generation intervals, the time between infection and onward transmission. Because generation intervals are difficult to observe, epidemiologists often substitute serial intervals, the time between symptom onset in successive links in a transmission chain. Recent studies suggest that such substitution biases estimates of R based on r. Here we explore how these intervals vary over the course of an epidemic, and the implications for R estimation. Forward-looking serial intervals, measuring time forward from symptom onset of an infector, correctly describe the renewal process of symptomatic cases and therefore reliably link R with r. In contrast, backward-looking intervals, which measure time backward, and intrinsic intervals, which neglect population-level dynamics, give incorrect R estimates. Forward-looking intervals are affected both by epidemic dynamics and by censoring, changing in ...
Statements in this press release that are not statements of historical or current fact constitute forward-looking statements within the meaning of the U.S. securities laws and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms believes, belief, expects, intends, projects, anticipates, will, should, likely or plans to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.. The forward-looking statements contained in this press release are expressly ...
Statements in this press release that are not statements of historical or current fact constitute forward-looking statements within the meaning of the U.S. securities laws and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms believes, belief, expects, intends, projects, anticipates, will, should or plans to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.. The forward-looking statements contained in this press release are expressly qualified in ...
Certain information on this Site contains certain forward-looking statements, which are subject to risks and uncertainties and speak only as of the date on which they are made. The words believe, estimate, expect, target, intend, may, plan or similar expressions are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. GWG Holdings undertakes no obligation to update publicly or revise any forward-looking statements. Actual results may differ materially from the expectations disclosed in the forward-looking statements made. Important factors that could cause actual results to differ materially from the companys forward-looking statements are described in GWG Holdings periodic reports, including the Annual Report on Form 10-K, quarterly reports on Form 10-Q and other reports filed with the Securities and Exchange Commission. Please click here to ...
Headline: Bitcoin & Blockchain Searches Exceed Trump! Blockchain Stocks Are Next!. Therapeutic Ultrasound Devices Market is expected to witness growth of international market with respect to advancements and innovations including development history, competitive analysis and regional development forecast.. The report starts with a basic Therapeutic Ultrasound Devices market overview. In this introductory section, the research report incorporates analysis of definitions, classifications, applications and industry chain structure. Besides this, the report also consists of development trends, competitive landscape analysis, and key regions development status.. Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Therapeutic Ultrasound Devices Market Research [email protected] https://www.360marketupdates.com/europe-therapeutic-ultrasound-devices-market-report-2017-10462799. Therapeutic Ultrasound Devices Market Key Players Analysis:. ...
Experience the amazing image quality delivered by the Vevo MD high frequency ultrasound system. View clinical ultrasound image examples.
This communication contains forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as expect, anticipate, intend, plan, believe, seek, see, will, would, target, similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, ...
ReSolve Asset Management Inc. (ReSolve). is registered as an investment fund manager in Ontario and Newfoundland and Labrador, and as a portfolio manager and exempt market dealer in Ontario, Alberta, British Columbia and Newfoundland and Labrador. In the U.S. ReSolve is registered with the United States Securities and Exchange Commission as a Non-Resident Investment Adviser.. Forward-Looking Information. The contents hereof may contain forward-looking information within the meaning of the Securities Act (Ontario) and equivalent legislation in other provinces and territories. Because such forward-looking information involves risks and uncertainties, actual performance results may differ materially from any expectations, projections or predictions made or implicated in such forward-looking information. Prospective investors are therefore cautioned not to place undue reliance on such forward-looking statements. In addition, in considering any prior performance information contained herein, ...
In some cases, forward-looking statements can be identified by terminology such as will, may, should, could, expects, intends, plans, aims, anticipates, believes, estimates, predicts, potential, continue, or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Modernas control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others: the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response technology in use by ...
This press release contains forward-looking statements about ORIC as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, statements regarding ORICs development plans; the ability of ORIC-101 to overcome resistance in cancer models; plans underlying ORIC-101 clinical trials and development; plans to report interim data from the two ongoing clinical trials of ORIC-101; and the potential advantages of ORICs product candidates. Words such as believes, anticipates, plans, expects, intends, will, goal, potential and similar expressions are intended to identify forward-looking statements. The forward-looking statements contained herein are based upon ORICs current expectations and involve assumptions that may never materialize or may prove to be incorrect. ...
Air-coupled ultrasonic techniques are being increasingly used for material characterization, non-destructive evaluation of composite materials using guided waves as well as for distance measurements. Application of those techniques is mainly limited by the big losses of ultrasonic signals due to attenuation and mismatch of the acoustic impedances of ultrasonic transducers and air. One of the ways to solve this problem is by application of novel more efficient piezoelectric materials like lead magnesium niobate-lead titanate (PMN-PT) type crystals. The objective of this research was the development and investigation of low frequency (<50 kHz) wide band air-coupled ultrasonic transducers and arrays with an improved performance using PMN-32%PT crystals. Results of finite element modelling and experimental investigations of the developed transducers and arrays are presented. For improvement of the performance strip-like matching elements made of low acoustic impedance, materials such as polystyrene foams
Discover Vevo® MD, the worlds first Ultra High Frequency ultrasound system for clinical use. Vevo® MD delivers the highest resolution possible in medical ultrasound when imaging the first 3cm of the body.
Cool new(er) technology might speed the time it takes to perform catheter ablation of atrial fibrillation: the high frequency ultrasound balloon. It has a fluid-filled inner chamber and an outer carbon dioxide-filled balloon that helps focus the ultrasound in a ring-like pattern in an attempt to ablate (or burn) around the pulmonary veins in the left atrium (the site where its thought the atrial fibrillation comes from). Average lesion time takes 40-90 seconds and it covers LOTS of territory in the left atrium. Its just starting clinical trials.... Seems promising. Well see ...
High Frequency Ultrasound Coagulating Cutter Market Research is expecting to accrue strong growth in forecasts frame, drive By Type, End User.
You are at: Home » Products » Disabilities » Ozone High Frequency Ultrasound / Ultrasonic Facia In total 213268 number ofProductsinfo,Released today. 0 number of ...
In this study, we will deploy annular-array systems and assess their experimental and clinical utility for ophthalmic imaging. We hypothesize that a 20-MHz annular array will detect posterior vitreous detachment (PVD) more reliably than a conventional single element ultrasound system. Clinically, we will test the hypothesis that 20-MHz annular arrays improve detection of PVD, an important risk factor for disease progression in diabetic retinopathy. Diabetic retinopathy is the leading cause of blindness in the working population (25 to 65 years) and the third major cause of legal blindness in the U.S.. We propose to carry out a study of 30 human subjects, aged 60 years or above, in whom PVD is likely to be present as a consequence of normal aging. The study will compare the ability to detect PVD using a commercial ophthalmic ultrasound system equipped with 10- and 20-MHz sector scan probes (Cinescan A/B-S, Quantel Medical), and OCT (OCT/SLO, Ophthalmic Technologies, Inc.), and the 20-MHz annular ...
0037] The present invention relates to an ultrasound coupling device suitable for use with low-profile ultrasound transducers and systems. The ultrasound coupling device of the present invention is particularly suitable for use with portable ultrasound devices, systems, and methods. Further, the ultrasound coupling device of the present invention can be configured to be either disposable or re-useable, and can be used with ultrasound transducers that are either disposable or re-usable. Therefore, in one aspect, the present invention provides an entirely autonomous ultrasound coupling device for use with portable ultrasound transducers and systems. In addition, the ultrasound coupling device of the present invention can be configured so as to enable the generation of ultrasonic energy from an ultrasound transducer or system. In this configuration, the ultrasound coupling device is configured so that ultrasonic energy is only transmitted when the ultrasound transducer is properly coupled with the ...
expected network coverage to new markets, expected expansion of 4G LTE bandwidth and the expected timing of closing the transaction, are forward-looking statements. Generally, forward-looking statements may be identified by words such as anticipate, expect, suggests, plan, believe, intend, estimates, targets, views, may, will, forecast, and other similar expressions. The forward-looking statements speak only as of the date made, are based on current assumptions and expectations, and involve a number of risks and uncertainties. Important factors that could affect future results and cause those results to differ materially from those expressed in the forward-looking statements include, among others, the following: adverse conditions in the U.S. and international economies and markets; our ability to successfully integrate the MetroPCS and ...
Item 2. Management s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and our annual report on Form 10-K dated December 31, 2014. Forward-Looking Statements This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These forward-looking statements are based on our management s belief and assumptions and on information currently available to management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events, including our clinical development plans, or our future financial performance and involve ...
Statements in articles on this blog other than purely historical information, historical estimates should not be relied upon, including statements relating to the companies future plans and objectives or expected results, are forward-looking statements. News releases contain certain Forward-Looking Statements within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the companies business, including risks inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements ...
This release contains forward-looking statements regarding our strategy, future plans and prospects, including statements regarding the development of the companys product candidates, the potential safety and efficacy profile of roxadustat, the potential for our Phase 3 program data to form the basis of a regulatory approval, our clinical and regulatory plans, and those of our partners. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions and are not historical facts and typically are identified by use of terms such as may, will, should, on track, could, expect, plan, anticipate, believe, estimate, predict, potential, continue and similar words, although some forward-looking statements are expressed differently. Our actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties related to the continued progress and timing of ...
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that Genvoya may not be approved by other regulatory authorities and the marketing applications for F/TAF and/or R/F/TAF may not be approved by the EMA, and marketing approvals, if granted, may have significant limitations on their use. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gileads Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such ...
This press release contains certain forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict, including statements regarding the Companys upcoming meeting with the FDA to discuss the adequate number and type of evaluable patients required for efficacy and safety necessary to support the filing of a Biologic License Application and our intention to continue enrolling patients in our CD02 combination trial. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as believes, hopes, intends, estimates, expects, projects, plans, anticipates and variations thereof, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Our forward-looking statements are not guarantees of performance and actual results could differ materially from those contained in or expressed by such statements. In ...
For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn. Forward-Looking Statement This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words and phrases such as aims, anticipates, believes, could, designed to, estimates, expects, forecasts, goal, intends, may, plans, possible, potential, seeks, will, and variations of these words and phrases or similar expressions that are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements regarding our business strategy for and the potential therapeutic benefits of our prospective product candidates, the design, commencement, enrollment and timing of ongoing or planned clinical trials, clinical trial results, product approvals and regulatory pathways, anticipated ...
This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as believes, expects, anticipates, intends, will, may, should, or similar expressions. These forward-looking statements reflect managements current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct or that those goals will be achieved, and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, our ability to successfully complete research and further development and commercialization of Company drug ...
is committed to improving the health of patients with kidney and vascular diseases through the development of novel, first-in-class therapeutics. Proteons lead product candidate, vonapanitase, is an investigational drug intended to improve hemodialysis vascular access outcomes. Proteon is currently enrolling patients in PATENCY-2, a Phase 3 clinical trial evaluating vonapanitase in patients with CKD undergoing surgical creation of a radiocephalic arteriovenous fistula for hemodialysis. Proteon is also evaluating vonapanitase in a Phase 1 clinical trial in patients with PAD. For more information, please visit www.proteontx.com.. Cautionary Note Regarding Forward-Looking Statements. This press release contains statements that are, or may be deemed to be, forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, including the terms estimates, ...
This press release includes forward-looking statements regarding the business of Akcea Therapeutics, Inc. and Ionis Pharmaceuticals, Inc. and the therapeutic and commercial potential of WAYLIVRATM (volanesorsen). Any statement describing Akceas or Ionis goals, expectations, financial or other projections, intentions or beliefs, including the commercial potential of WAYLIVRA or other of Akceas or Ionis drugs in development is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. Akceas and Ionis forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking ...
Forward-Looking Statements Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the advancement, therapeutic indication and use, safety, efficacy, tolerability, mechanism of action and potential of lorcaserin; the significance of the PWG s re-adjudication and the CSF study, including the potential use of the results; the response to the CRL for the lorcaserin NDA, including related plans, activities and timing; the therapeutic indication of APD811; and Arena s views, focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena s expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are ...
We offer a variety of servo gearboxes and although they may appear the same, they function differently. Kyle goes through each style of gearbox and when they would be ideal for specific projects.. Channel Gearboxes: Designed to mount inside Actobotics Channel. Great for robotic arms and projects that have limited space. 1/2 output shaft.. Top Flange Gearboxes: Designed to be flush mounted with the tabs protruding from the top plane of the gearbox. Excellent for R/C sailboats. 3/8 output shaft.. Bottom Flange Gearboxes: Designed to be mounted to a flat surface with the bottom flanges. Great for FPV antenna trackers and base gearboxes on robotic arms. 3/8 output shaft.. Square Tube Gearboxes: Sleek, rectangular profile with mounting options on the ends and sides. 1/2 output shaft (1 shaft available on some models).. ...
Piezoelectric materials are utilized for high-power ultrasonic devices such as ultrasonic motors, which are driven under high stress and strain. The nonlinear elastic vibration of piezoelectric materials is a critical problem because it degrades the output performance. (Bi,Na)TiO3-BaTiO3 (BNBT) ceramics are one of the lead-free piezoelectric materials that show outstanding characteristics under high power driving, such as stable mechanical quality factor and resonance frequency. We evaluated the high-power characteristics of BNBT ceramics by measuring complex higher-order elastic constants using a nonlinear piezoelectric vibration model. We found that the absolute value of the higher-order elastic constant of BNBT was less than 4% of Pb(Zr,Ti)O3 (PZT). Additionally, we developed a miniature ultrasonic motor using a BNBT multilayered piezoelectric transducer. This multilayered structure was utilized to enhance the piezoelectric displacement and was equipped with elastic fins, which convert the ...
A device for acquiring data and diagnosing a musculoskeletal injury. The device includes a semi-flexible housing, at least one ultrasonic transducer, a positional localizer, and a transmission system. The semi-flexible housing is positioned proximate a portion of the musculoskeletal system of a patient and supports the at least one ultrasonic transducer and the positional localizer. The at least one ultrasonic transducer is configured to acquire an ultrasonic data indicative of a bone surface. The positional localizer is positioned at a select location relative to the at least one ultrasonic transducer and tracks movement of the housing. The transmission system transmits the ultrasonic data of the at least one ultrasonic transducer and the movement data of the positional localizer to a data analyzer for analysis and diagnosis.
At O-I Glass, Inc. (NYSE: OI), we love glass and were proud to make more of it than any other glass bottle or jar producer in the world. We love that its beautiful, pure and completely recyclable. With global headquarters in Perrysburg, Ohio, we are the preferred partner for many of the worlds leading food and beverage brands. Working hand and hand with our customers, we give our passion and expertise to make their bottles iconic and help build their brands around the world. With more than 26,500 people at 78 plants in 23 countries, O-I Glass has a global impact, achieving revenues of $6.9 billion in 2018. For more information, visit o-i.com.. Forward-Looking Statements. This press release contains forward-looking statements related to O-I Glass, Inc. (O-I Glass or the Company) within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act) and Section 27A of the Securities Act of 1933. These forward-looking statements relate to a variety of ...
This press release contains forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, about ADMA Biologics, Inc. (we, our or the Company). Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words estimate, project, intend, forecast, target, anticipate, plan, planning, expect, believe, will, is likely, will likely, should, could, would, may, or, in each case, their negative, or words or expressions of similar meaning. These forward-looking statements also include, but are not limited to, statements concerning our plans to develop, manufacture, market, launch and expand our own commercial infrastructure and commercialize our current products and future products, the safety, efficacy and expected timing of, and our ability to, obtain and maintain regulatory ...
This press release contains forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, about ADMA Biologics, Inc. (we, our or the Company). Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words estimate, project, intend, forecast, target, anticipate, plan, planning, expect, believe, will, is likely, will likely, should, could, would, may, or, in each case, their negative, or words or expressions of similar meaning. These forward-looking statements also include, but are not limited to, statements concerning our plans to develop, manufacture, market, launch and expand our own commercial infrastructure and commercialize our current products and future products, the safety, efficacy and expected timing of, and our ability to, obtain and maintain regulatory ...
First Majestic is a mining company focused on silver production in México and is aggressively pursuing the development of its existing mineral property assets and the pursuit through acquisition of additional mineral assets which contribute to the Company achieving its corporate growth objectives.. FIRST MAJESTIC SILVER CORP.. Keith Neumeyer, President & CEO Cautionary Note Regarding Forward-Looking Statements. This press release contains forward-looking statements, within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, concerning the business, operations and financial performance and condition of First Majestic Silver Corp. Forward-looking statements include, but are not limited to, statements with respect to the future price of silver and other metals, the estimation of mineral reserves and resources, the realization of mineral reserve estimates, the timing and amount of estimated future production, costs of ...
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, and pre-clinical nucleic acid-based therapeutic drug candidates. Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW. Forward-Looking Statements The statements made by Applied DNA in this press release may be forward-looking in nature within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNAs future plans, projections, strategies and expectations, and ...
This news release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on managements current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in any forward-looking statements: competitive pressures; the loss of one or more key customer or supplier relationships; customer defaults or insolvencies; changes in customer mix; supplier defaults or insolvencies; changes in pharmaceutical manufacturers pricing and distribution policies or practices; adverse resolution of any contract or other disputes with customers (including departments and agencies of the U.S. Government) or suppliers; regulatory changes (including increased ...
This press release contains forward-looking statements, including statements that relate to, among other things, revenue forecasts, technology development progress, plans for shipment using the Companys technology, production plans, the Companys markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as may, will, could, should, would, likely, possible, expect, intend, estimate, anticipate, believe, plan, objective and continue (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied ...